Enara Bio is a startup based in France, most recent round Series B, 1 tracked investor.
Enara Bio is a startup based in France. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
Enara Bio is a biopharmaceutical company pioneering the discovery of novel Dark Antigens and the development of bispecific T-cell engagers for solid tumors. It utilizes its proprietary EDAPT platform to discover cancer-specific targets derived from previously unexplored regions of the genome, known as the 'dark genome', and employs the EnTiCE platform to develop potent immunotherapies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.